D353-0307 Screening compound: N-[(1H-1,3-benzodiazol-2-yl)methyl]-2-{[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide

D353-0307 Screening compound: N-[(1H-1,3-benzodiazol-2-yl)methyl]-2-{[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide
D353-0307 Screening compound: N-[(1H-1,3-benzodiazol-2-yl)methyl]-2-{[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D353-0307
N-[(1H-1,3-benzodiazol-2-yl)methyl]-2-{[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D353-0307

Molecular Formula

C20H19N5O3S (C20 H19 N5 O3 S)

Compound Name

N-[(1H-1,3-benzodiazol-2-yl)methyl]-2-{[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide

IUPAC name

N-[(1H-13-benzodiazol-2-yl)methyl]-2-{[5-(4-ethoxyphenyl)-134-oxadiazol-2-yl]sulfanyl}acetamide

SMILES

CCOc(cc1)ccc1-c(o1)nnc1SCC(NCc1nc(cccc2)c2[nH]1)=O

InChI

InChI=1S/C20H19N5O3S/c1-2-27-14-9-7-13(8-10-14)19-24-25-20(28-19)29-12-18(26)21-11-17-22-15-5-3-4-6-16(15)23-17/h3-10H,2,11-12H2,1H3,(H,21,26)(H,22,23)

InChI Key

HESXDQLVOHHKIL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14822332

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

409.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.107

Distribution Coefficient, logD

3.106

Water Solubility, LogSw

-3.23

Polar Surface Area

81.941

Acid Dissociation Constant (pKa)

12.34

Base Dissociation Constant (pKb)

4.90

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

D353-0307 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D353-0307 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D353-0307?
Check Price and Availability of D353-0307, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D353-0307 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D353-0307
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D353-0307
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D353-0307 available by request